TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
109 hedge funds and large institutions have $18.3M invested in Tvardi Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-12
Holders Change %
-9.92%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
30
Reduced
34
Closed
29
Calls
$46K
Puts
$11K
Net Calls
+$35K
Net Calls Change
-$48K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$286K |
| 2 |
Two Sigma Advisers
New York
|
+$280K |
| 3 |
Morgan Stanley
New York
|
+$197K |
| 4 |
Two Sigma Investments
New York
|
+$176K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$168K |
Top Sellers
| 1 |
ClearBridge Investments
New York
|
-$1.63M |
| 2 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
-$1.43M |
| 3 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$980K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$555K |
| 5 |
PA
Pinnacle Associates
New York
|
-$473K |
